Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosomal binding domain 2 pseudogene 35 (HMGN2P35) is a genomic DNA sequence with high homology to the functional gene encoding the high mobility group nucleosomal binding domain protein 2 (HMGN2), but HMGN2P35 itself is classified as a pseudogene and is incapable of producing a functional protein product[1][4]. Pseudogenes like HMGN2P35 can sometimes have noncoding RNA functions such as sequestering microRNAs or affecting parental gene regulation, but there is no specific evidence that HMGN2P35 has such effects[3]. It is not considered a therapeutic target and is not implicated in any specific diseases or targeted by any drugs[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 35 (HMGN2P35).